Profusa (NVACW) Income from Continuing Operations (2022 - 2026)
Profusa (NVACW) reported Income from Continuing Operations of 4024000.0 for Q1 2026, down 259.31% on a YoY basis from 2525820.18 in Q1 2025, and up 13.43% quarter-over-quarter from 4648000.0 in Q4 2025.
Profusa (NVACW) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Profusa has reported Income from Continuing Operations for 5 years, with the latest figure at 4024000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 259.31% year-over-year to 4024000.0; the trailing twelve-month figure through Mar 2026 stood at 38746876.0 (down 329.33% YoY), and the FY2025 full-year result was 30227000.0, down 246.43% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 4024000.0, up from 4648000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3709017.0 in Q1 2022, with the low at 21878000.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 2369746.88 across 5 years, with a median of 367345.0 in 2023.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations jumped 124.82% — and 2025, when it slumped 24095.09%.
- Profusa's Income from Continuing Operations stood at 482545.0 in 2022, then plunged by 55.92% to 212692.0 in 2023, then plunged by 3672.63% to 7598693.0 in 2024, then surged by 38.83% to 4648000.0 in 2025, then advanced by 13.43% to 4024000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 4024000.0 (Q1 2026), 4648000.0 (Q4 2025), and 21878000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Profusa | - | - | - | -4.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02 Mn |
| Dec 31, 2025 | -4.65 Mn |
| Sep 30, 2025 | -21.88 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -7.60 Mn |
| Sep 30, 2024 | 91,177.00 |
| Jun 30, 2024 | -397,487.00 |
| Mar 31, 2024 | -820,277.00 |
| Dec 31, 2023 | 212,692.00 |
| Sep 30, 2023 | -367,345.00 |
| Jun 30, 2023 | 852,389.00 |
| Mar 31, 2023 | 440,895.00 |
| Dec 31, 2022 | 482,545.00 |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 3.71 Mn |